Latest Breaking News On - Aptorum group limited - Page 11 : comparemela.com

Aptorum Group Limited and ASP Isotopes Inc Interviews to Air on Bloomberg U S on the RedChip Money Report(R)

Aptorum Group Limited and ASP Isotopes Inc Interviews to Air on Bloomberg U S on the RedChip Money Report(R)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth africaBoca ratonDaptorum groupIsotopes incAptorum group limited nasdaqSingapore agency for scienceRedchip companies incRedchip companiesAptorum group limitedEuronext parisRedchip money reportGroup limitedInvestor relationsDiscovering tomorrowBlue chips

Aptorum Group Limited and ASP Isotopes Inc Interviews to Air on Bloomberg U S on the RedChip Money Report

ORLANDO, FL / ACCESSWIRE / March 17, 2023 / RedChip Companies will air new interviews with Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) and ASP Isotopes Inc. (Nasdaq:ASPI) on The RedChip Money

United statesSouth africaBoca ratonDennis riedlDaptorum groupIsotopes incAptorum group limited nasdaqSingapore agency for scienceRedchip companies incRedchip companiesAptorum group limitedEuronext parisRedchip money reportGroup limitedInvestor relationsDiscovering tomorrow

Aptorum Group Limited: Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announces the completion of an end of Phase 1

Dennis riedlClark chengCraig brelsfordGhislaine gasparettoAptorum group formAptorum group orDrug administrationSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqRegulatory newsGroup limitedEuronext parisChief medical officer

Aptorum Group Limited: Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announces the completion of the Pre-IND discussions

United statesDennis riedlClark chengCraig brelsfordGhislaine gasparettoAptorum group formAptorum group orDrug administrationSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqRegulatory newsGroup limitedEuronext paris

Aptorum Group Limited: Aptorum Group Launches NativusWell, a Novel Nutraceutical for Menopause, in China

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group"), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to tackling

United statesUnited kingdomDennis riedlCraig brelsfordGhislaine gasparettoAptorum group formInvestor relations departmentSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqRegulatory newsGroup limitedEuronext parisMol struct